CNTX — Context Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $1.74m
- $123.04m
Annual cashflow statement for Context Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6.64 | -10.5 | -14.8 | -24 | -26.7 |
| Depreciation | |||||
| Non-Cash Items | -9 | 3.88 | 1.55 | 1.13 | 15.6 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.32 | -2.22 | -0.278 | 1.78 | -3.48 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -1.03 | -8.8 | -13.5 | -21 | -14.6 |
| Capital Expenditures | — | — | -0.037 | 0 | -0.007 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.25 | -0.5 | 0 | -14.8 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.25 | -0.537 | 0 | -14.8 |
| Financing Cash Flow Items | — | — | -0.102 | 0 | 94.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.15 | 58.4 | -0.102 | 0 | 109 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.114 | 49.3 | -14.2 | -21 | 80 |